Cooper Webb rode to a hard-fought victory on Saturday during Supercross’s Round 6 race at Ford Field in Detroit. It was ...

BOSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel ...

Through the first five rounds of the 2025 season, Lawrence has only one overall race win to his name and has faced stiff competition from fellow champions Eli Tomac and Chase ... from Ken Roczen ...

A family who said they could hear hospital staff laughing in a nearby room as their son was taken off life support were given "poor bereavement" care, an investigation has found. Five-year-old ...

Ken Roczen leads 450 racers in overall points; Tomac and Jett Lawrence tied for third Cortez’s Eli Tomac won the round three Supercross 450SX heat race at Angel Stadium in Anaheim before placing ...

Donald Trump on Monday once again publicly pondered the possibility of running for president for a third term. Trump asked House Speaker Mike Johnson (R-La.) if he’d be “allowed to” during an address ...

Philadelphia Eagles running back Saquon Barkley opened up the NFC championship game on Sunday afternoon with a monster, 60-yard touchdown run. The scamper—on Philly's first play from scrimmage ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

“It’s an absolute dream,” Roczen said of his new position as championship leader, “After I was in a position last week for a possible third, I came back [to the truck and] was thinking it would be so ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...